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HPLCAbstract A stability-indicating high-performance liquid chromatography (HPLC) of hydrophilic
interactions was developed and validated for the determination of cetirizine dihydrochloride in bulk
substance and in pharmaceutical dosage form. The separation was achieved on a Poroshell 120 Hilic
(4.6  150 mm, 2.7 lm) column using a mobile phase composed of acetonitrile–0.1% formic acid
(20:80 v/v) at a ﬂow rate of 1.0 mL/min. The injection volumewas 5.0 lL and the wavelength of detec-
tion was controlled at 235 nm. The method was validated by evaluating linearity, accuracy, precision,
selectivity and robustness. Cetirizine dihydrochloride was the susceptible to the action of an oxidation
factor. The product of its degradation under those conditions was identiﬁed with an EIS-Q-MS mass
spectrometer. The hydrophilic interactions between the main analyte, its oxidation product, and the
mobile and stationary phases were discussed with the support of a theoretical investigation.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cetirizine dihydrochloride (CTZ), chemically known as [2-[4-[(4-chlor
ophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetic acid dihydrochlo-
ride, is an antagonist of a H1 receptor. CTZ is a racemic mixture of
levocetirizine, showing biological antihistamine activity, and dextroce-
tirizine, with no such effect (Baltes et al., 2001). The difference in the
molecular structures of the enantiomers affects their pharmacological
properties, including an afﬁnity to the receptor being 30 times greaterfor levocetirizine (Tillement et al., 2003). CTZ is used in the treatment
of hay fever, allergies, angioedema, and urticaria. It belongs to the
second-generation antihistamines that are less able to cross the
blood–brain barrier and thus do not cause side effects such as sedation,
drowsiness or decreased cognitive processing (Berger et al., 2006;
Carson et al., 2010; Garg and Thami, 2007; Golightly and Greos,
2005; Howarth et al., 1999). In previous studies, spectrophotometric,
HPTLC and HPLC methods have been applied for determining ceti-
rizine hydrochloride (Arayne et al., 2005; Haghighi et al., 2013;
Kaur et al., 2014; Khan et al., 2011; Rawool et al., 2013; Souri
et al., 2013). So far only one report has presented a UHPLC procedure
for CTZ determination, conducted in the presence of ambroxol
hydrochloride and antimicrobial preservatives in liquid pharmaceutical
formulations (Trivedi et al., 2011). All of those methods utilized clas-
sical stationary phases known from reversed-phase liquid chromatog-
raphy. Moreover for the separation of cetirizine enantiomers were
also proposed: HPLC method developed by Kang et al. (2010) andde. Ara-
2 M. Paczkowska et al.capillary electrophoresis (CE) obtained by Eeckhaut and Michotte
(2006). Recently supercritical ﬂuid chromatography was reported as
fast method for chiral separation of racemic cetirizine and levoceti-
rizine (Eom et al., 2016). However, it is worth noting that Pharma-
copeia recommended potentiometric titration as a method for
cetirizine determination, while chromatographic separation was signed
as method for separation of A-F impurities of cetirizine (including
levocetirizine) (European Pharmacopoeia; British Pharmacopoeia).
Currently, the interest in the application of hydrophilic interaction
chromatography (HILIC) in the analysis of many polar drugs, metabo-
lites and biological important compounds was observed (Nuijs et al.,
2011). According to Buszewski and Noga (2012), the application of
hydrophilic interaction liquid chromatography (HILIC) is a viable
alternative to high-performance liquid chromatography in the analysis
of many compounds. HILIC is also applicable to charged substances
(Bertuzzi et al., 2010). It is also equally important that separation by
this method, while analyzing hydrophilic and ionizable drugs, can be
combined with mass spectroscopy (MS) resulting in a signiﬁcantly
increased sensitivity of determination (Sewell et al., 2012).
Earlier studies have shown that cetirizine dihydrochloride is stable
under conditions of base hydrolysis (1 M NaOH) and thermolysis
(T= 43 K, RH= 76.4%), whereas strong affecting factors are
required to degrade CTZ in an acidic environment (2 M HCl,
T= 343 K). The greatest chemical instability of CTZ is observed on
exposure to an oxidation factor (2%H2O2, T= 53 K), which is of par-
ticular practical importance indicating that excipients promoting an
oxidative degradation path must be avoided (Khan et al., 2011).
Based on the above, the present study aimed to develop a rapid and
sensitiveHPLC–HILICmethod for the determination of cetirizine dihy-
drochloride in the presence of its degradation product and excipients
found in solid pharmaceutical dosage forms containing this compound.
The method is useful for quality control of cetirizine dihydrochloride in
biological ﬂuids and in pharmaceutical matrix.
2. Experimental
2.1. Materials
Cetirizine dihydrochloride (purity > 98%, molecular weight:
461.81 g/mol, pKa (strongest acidic): 3.6, pKa (strongest
basic): 7.79, log P: 1.70, solubility in water: 0.0658 mg/mL at
298 K) in bulk substance was applied by India PVT LTD,
while pharmaceutical preparation 1: containing 10 mg of
CTZ and excipients: microcrystalline cellulose, lactose mono-
hydrate, colloidal silica, magnesium stearate; pharmaceutical
preparation 2: containing 10 mg of CTZ and excipients: lactose
monohydrate, microcrystalline cellulose, starch, crospovidone,
magnesium stearate; and pharmaceutical preparation 3:
containing 10 mg of CTZ and excipients: lactose monohydrate,
microcrystalline cellulose, cornstarch, povidone, magnesium
stearate, were commercially available preparations.
Hydrochloric acid, sodium hydroxide solution, hydrogen
peroxide and all other chemicals were obtained from P.O.Ch.
(Poland). Acetonitrile of an HPLC grade was supplied by
Merck KGaA (Germany) and formic acid (100%) by P.O.
Ch. (Poland). High-quality pure water was prepared using an
Exil SA 67120 Millipore puriﬁcation system (France).
2.2. Chromatographic equipment and chromatographic
conditions
TheLC system (DionexThermoline Fisher Scientiﬁc,Germany)
was equipped with a high pressure pump (UltiMate 3000), an
autosampler (UltiMate 3000) and a DAD detector (UltiMatePlease cite this article in press as: Paczkowska, M. et al., Hydrophilic interaction chr
bian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.05.0123000). For data processing and acquisition, Chromeleon
software version 7.0 from Dionex Thermoline Fisher Scientiﬁc
(US) was used. As the stationary phase, a Poroshell 120 Hilic
column, 2.7 lm particle size, 4.6  150 mm (Agilent
Technology) was used. The mobile phase consisted of acetoni-
trile–0.1% formic acid (20:80 v/v). The ﬂow rate of the mobile
phase was 1.0 mL/min. The wavelength of the UV detector
was set at 235 nm. The injection volume was 5.0 lL. A triple-
quadrupole mass spectrometer model 6410B Triple Quad with
an electrospray (ESI) interface (both from Agilent Technolo-
gies, USA) coupled with chromatograph Agilent 1200 was used
for identiﬁcation of degradation products of CTZ. The ESI
source of theMS-detector was operated in a negative ionization
mode. For nebulization a nitrogen stream at 40 psi (275.8 kPa)
was applied. A drying gas, also nitrogen, was delivered at a ﬂow
rate of 8 L/min at 573 K. The electrospray needle voltage was
4000 V. The acquisition was carried out in the scan mode, and
the spectra were collected in the range of m/z 40–600. The
MassHunter workstation software (Agilent Technologies,
USA) was used for the instrument control, data acquisition
and data analysis. The identiﬁcation of degradation products
of CTZ based on application of an EIS-Q-MS mass spectrome-
ter was possible by using the mobile phase which was composed
of acetonitrile and 0.1% formic acid (20:80 v/v).
2.3. Preparation of analytical samples
2.3.1. Assay of in bulk substance
Solutions ofCTZwere preparedbydissolving 10.0 mgofCTZ in
20.0 mL of distilled water (c= 0.5 mg/mL). Standard stock
solution of CTZ was prepared by the same way
(c= 0.5 mg/mL). Standard stock solution was kept during
period of studies.
2.3.2. Assay of cetirizine dihydrochloride in tablets
The amount of accurately powdered tablets (pharmaceutical
preparations 1, 2, 3) containing CTZ was pounded and trans-
ferred to 20.0 mL volumetric ﬂasks, dissolved with about
20 mL of water, mixed in a ultrasound bath for 5 min and
ﬁltered. The ﬁnal concentration of CTZ 0.5 mg/mL was
achieved.
2.4. Method validation
The method was validated according to the International
Conference on Harmonization Guidelines (1996). It comprised
selectivity, linearity, accuracy, precision, limits of detection
(LOD) and quantitation (LOQ). All measurements were
performed triplicates.
2.4.1. Sample solutions
Sample solution of CZT was prepared by dissolving 10.0 mg of
CTZ in 20.0 mL of distilled water. Pharmaceutical prepara-
tions 1, 2 and 3 (10 mg coated tablets), commercially available
dosage form of CTZ were pounded, transferred into stopped
ﬂask and dissolved in 20.0 mL of distilled water.
2.4.2. Selectivity
The selectivity of determination of CTZ was examined for
non-degraded and degraded samples as well as in the presenceomatography (HILIC) for the determination of cetirizine dihydrochloride. Ara-
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colloidal silica, magnesium stearate, starch, cornstarch,
povidone and crospovidone). The selectivity was examined
after stress conditions in aqueous solutions after oxidation
(2% H2O2 at 353 K).
In order to evaluate the selectivity of proposed HPLC
method in determination of CTZ in bulk substance and in
pharmaceutical dosage forms in the presence of excipients
(microcrystalline cellulose, lactose monohydrate, colloidal sil-
ica, magnesium stearate, starch, cornstarch, povidone and
crospovidone) degradation studies in aqueous solutions after
oxidation (2% H2O2 at 353 K) were performed. The identiﬁca-
tion of degradation products of CTZ was carried in the same
conditions.
2.4.3. Precision
Precision of the assay of CTZ was determined in relation to
repeatability (intra-day) and intermediate precision (inter-
day). In order to evaluate the repeatability of the method,
six samples were determined during the same day for three
concentrations of CTZ. Intermediate precision was studied
comparing the assays performed on two different days.
2.4.4. Accuracy
The accuracy of the method was determined by recovering
CTZ from the placebo. The recovery test was performed at
three levels: 80%, 100%, and 120% of the nominal concentra-
tion of CTZ during degradation studies. Three samples were
prepared for each recovery level. The solutions were analyzed
and the percentage of recoveries was calculated from the cali-
bration curves.
2.4.5. The limit of detection (LOD) and quantification (LOQ)
LOD and LOQ parameters were determined from the regres-
sion equations of CTZ. LOD= 3.3 Sy/a, LOQ= 10 Sy/a,
where Sy is a standard error and a is the slope of the corre-
sponding calibration curve.
2.4.6. Robustness
The impact of the composition of the mobile phase (percentage
of acetonitrile in the mobile phase 20 ± 5 v/v), pH of mobile
phase (formic acid concentration, 3–0.05%), the ﬂow rate
(1.0 ± 0.1 mL/min), absorption wavelength (235 ± 5 nm)
and column temperature (25 ± 10 C) on the peak area and
shape of CTZ were determined.
2.5. Theoretical studies
Molecular electrostatic potential (MEP) of optimized struc-
tures of CTZ and its degradation product were obtained with
density functional theory calculations using Becke’s three-
parameter hybrid functional (B3LYP) with 6-31++(d,p)
basis set. All ab initio calculations were carried out by Gaus-
sian 03 package. GaussView application was utilized to pre-
sent the MEP maps (Frisch et al., 2009). Modeling and
visualization of fragment of stationary phase were made
using molecular mechanics MMFF94 method implemented
in ChemBio3D. Prediction of pKa values was carried out
by ePik software.Please cite this article in press as: Paczkowska, M. et al., Hydrophilic interaction chr
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The HPLC procedure was developed in regard to stability-
indicating assay of CTZ in bulk substance and pharmaceutical
dosage forms. The chromatographic separation of CTZ and its
degradation products were achieved on a Poroshell 120 Hilic
column, 2.7 lm particle size (4.6  150 mm) at 25 C. A mix-
ture of acetonitrile and 0.1% formic acid (20:80 v/v) with a
ﬂow rate of 1.0 mL/min was used as a mobile phase. The wave-
length of detection was set at 235 nm. The chromatograms of
non-degraded and degraded samples CTZ are shown in Fig. 1.
On chromatograms of degraded samples of CTZ, peaks origi-
nating from degradation product were observed at retention
times from about 1.65 (Fig. 1). The degradants and excipients
were not interfering with the main peaks. As a result of exploit-
ing hydrophilic interactions in the determination of CTZ by
using HPLC in this work, it was possible to obtain shorter
retention times for CTZ (tR = 1.79 min) compared to values
received with HPLC (tR = 3.8 min and tR = 7.0 min)
(Kaur et al., 2014; Souri et al., 2013). The use of a hydrophilic
interactions in HILIC ensuring a high selectivity of CTZ deter-
mination in the presence of oxidation products without using
phosphate buffers allowed an analysis of degradation products
by means of an EIS-Q-MS mass spectrometer. Buszewski
noted that the advantage of coupling HILIC with an MS
detector is a tenfold increase in sensitivity as against HPLC-
MS systems due to the presence of a higher organic content
in the mobile phase (20% in this study) leading to rapid solvent
evaporation during electrospray ionization (Buszewski and
Noga, 2012).
The method was also validated for linearity, inter- and intra-
day accuracy and precision, robustness, system suitability,
LOD, LOQ and recovery for the assay of CTZ in bulk substance
and in the pharmaceutical preparations. The calibration plots
were linear and in CTZ column load range 0.50–3.00 lg/mL.
They were described by the equations y= ax. The b values,
calculated from the equation y= ax+ b, were insigniﬁcant
becauseof being lower than the critical value tb = b/Sb (Table 1).
Precision of the proposed method was characterized by relative
standard deviation (RSD, %) which was calculated for six
consecutive measurements at three concentration levels 80%,
100% and 120% of standard solutions during the system suit-
ability test. All values that characterize the inter-day precision
of determination of cetirizine dihydrochloride were less than
2% and meet the criteria required for the precision of the
method. The accuracy of the developed HPLC method was
evaluated by analyzing content of cetirizine dihydrochloride in
bulk substance and in pharmaceutical preparations. Although
the content of organic fraction in the mobile phase was low
for the HILIC application in our studies, the high sensitivity
of determination analytes was achieved. The average values of
the recoveries and precision are collected in Table 2.
A comparison of validation parameters obtained in the
present study with those reported previously demonstrated
that the newly developed method is far more sensitive,
provides a wider range of linear relation between analyte con-
centration and a detector signal, and allows receiving lower
limits of quantitation and detection. With regard to %RSD
reﬂecting the intra-day precision of the methods compared,
HPLC procedures proved superior whereas no signiﬁcant
differences were found in inter-day precision. The accuracyomatography (HILIC) for the determination of cetirizine dihydrochloride. Ara-
Figure 1 The chromatograms of non-degraded samples of CTZ in a bulk substance (A) and degraded samples of CTZ in bulk substance
under oxidizing conditions (2% H2O2, T= 53 K, t= 40 min) (B).
Table 1 Validation parameters of linearity of CTZ in a bulk substance and pharmaceutical preparations.
Bulk substance Pharmaceutical preparations
1 2 3
Retention time (min) 1.970 1.977 1.980 1.980
Range of linearity (lg/mL) 0.50–3.00 0.50–3.00 0.50–3.00 0.50–3.00
Regression equation (y)
Slope (a± Sa) 25.32 ± 0.28 20.57 ± 0.45 21.19 ± 0.24 23.53 ± 0.39
Correlation coeﬃcient (r) 0.9999 0.9996 0.9999 0.9998
LOD (lg/mL) 0.0373 0.0737 0.0384 0.0553
LOQ (lg/mL) 0.1131 0.2236 0.1164 0.1475
Sa standard deviation of slope; Sb standard deviation of intercept, t, calculated values of Student’s t test, ta,f = 2.1709 critical values of Student’s
test for degrees of freedom f= 11 and signiﬁcance level a= 0.05.
4 M. Paczkowska et al.of the HPLC method involving hydrophilic interactions was
slightly worse compared to a HPLC procedure with a C18 col-
umn used as a stationary phase (Kaur et al., 2014; Souri et al.,
2013; Trivedi et al., 2011).Please cite this article in press as: Paczkowska, M. et al., Hydrophilic interaction chr
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ated after changing the mobile phase composition (acetonitrile
volume, 20 ± 5 v/v), mobile phase pH (formic acid concentra-
tion, 3–0.05%), ﬂow rate (1.0 ± 0.1 mL/min), absorptionomatography (HILIC) for the determination of cetirizine dihydrochloride. Ara-
Table 2 Results for the determination of CTZ in a bulk substance and pharmaceutical dosage forms.
Bulk substance Pharmaceutical preparations
1 2 3
Column load, lg RSD, %
Intra-day precision
4.0 (80%) 0.09 0.21 0.67 0.57
5.0 (100%) 0.51 1.14 0.24 0.17
6.0 (120%) 0.83 1.25 0.08 0.87
Inter-day precision
4.0 (80%) 0.08 1.49 0.28 0.46
5.0 (100%) 0.01 0.48 1.23 1.25
6.0 (120%) 0.12 1.11 0.75 0.39
Accuracy, %
4.0 (80%) 100.13 79.74 93.61 83.04
5.0 (100%) 100.06 80.97 93.89 84.77
6.0 (120%) 100.06 82.20 94.42 84.92
Table 3 System suitability tests of the HPLC-DAD for CTZ determination under oxidizing factor (2% H2O2, T= 53 K, t= 30 min).
Parameter CTZ DP
Relative standard deviation of peak area % 0.09 0.17
Relative standard deviation of retention time (min) % 0.03 0.03
Peak purity 99.79 99.52
Resolution 1.28 1.35
Asymmetry (tailing factor) 1.54 1.79
Number of theoretical plates 2775 3036
Resolutions were calculated between two adjacent peaks in no-degraded and degraded samples.
DP – degradation product.
H
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O
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Cl
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Figure 2 Degradation pathways of cetirizine hydrochloride during oxidation.
Determination of cetirizine dihydrochloride 5wavelength (235 ± 5 nm) and column temperature
(298 ± 10 K). No statistically signiﬁcant differences were
established for the parameters studied in the investigation of
robustness as their deviation did not exceed the permissiblePlease cite this article in press as: Paczkowska, M. et al., Hydrophilic interaction chr
bian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.05.012range of ±2%. System suitability was examined in regard to
the relative standard deviation for peak areas and peak times,
peak resolution, peak asymmetry and the number of
theoretical plates (Table 3).omatography (HILIC) for the determination of cetirizine dihydrochloride. Ara-
Figure 3 Dipole moment vectors of CTZ (A) and degradation product (B). Electrostatic potential maps of CTZ (C) and its degradation
product (D).
Figure 4 Model of CTZ – silanol stationary phase system (A)
and model of degradation product – silanol stationary phase
system (B).
6 M. Paczkowska et al.The action of an oxidation factor (2% H2O2) caused
changes within the bond connecting the phenyl and the piper-
azine rings resulting in the formation of a degradation product
with a partition coefﬁcient different from that of the analyte.
The mass fragmentation of the CTZ during oxidation is shown
in Fig. 2. The resulting oxidation product of cetirizine has not
been previously reported as its impurity (European
Pharmacopoeia; British Pharmacopoeia). As demonstrated,
the degradation product of CTZ oxidation meets the criteria
of Lewis base being an electron donor and thus can be
assumed to interact with negatively charged silanols from the
stationary phase. By contrast, CTZ is a polar compound with
a tendency to form hydrogen bonds and numerous physical
interactions (e.g. an ion–dipole or a dipole-induced dipole) as
a consequence of being an electron acceptor. According to
Yoshida, the fact of obtaining similar retention times
(tR = 1.65 min vs tR = 1.95 min) for two different com-
pounds, CTZ and its degradation product during separation
conﬁrms the occurrence of both hydrogen bonding (Lewis
acidity/basicity) and dipole–dipole interactions (dipole
moments and compound polarizability) in separation based
on application of HILIC column (Yoshida, 2004). The order
of elution results from a shift in the partition equilibrium
toward the immobilized water layer on the stationary phase
for the more hydrophilic analyte; therefore, cetirizine dihy-
drochloride was eluted after its degradation product.
Based on parameters of molecular electrostatic potential
(MEP), which are useful descriptors in indicating sites for
electrophilic/nucleophilic reactions and hydrogen bonding, a
proposition was made as to which molecular domains of
cetirizine dihydrochloride and its oxidation product
participated in hydrophilic interactions with the stationary
phase. In order to model behavior of CTZ and its degradationPlease cite this article in press as: Paczkowska, M. et al., Hydrophilic interaction chromatography (HILIC) for the determination of cetirizine dihydrochloride. Ara-
bian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.05.012
Determination of cetirizine dihydrochloride 7product in proximity of silanol groups, theoretical calculations
were performed. Both CTZ and degradation product were
subjected to pKa calculationswhich resulted in protonated form
of CTZ in pH= 6.5 (±0.74). The protonation took place on
nitrogen of piperazine ring and causes increased polarity of
molecule. Dipole vectors computed for optimized geometries
of protonatedCTZ (Fig. 3A) and degradation product (Fig. 3B)
were presented. Vector values are 13.26 Debye and 5.78 Debye
for CTZ and degradation product, respectively. Electrostatic
potential was visualized on ESP maps (Fig. 3C and D). Blue
color indicates positive charge, which is mostly susceptible on
interactions with negatively charged stationary phase. High
electric dipole moment of CTZ conﬁrms higher polarity, and
thus stronger retention relatively to degradation product. Sim-
pliﬁed model of absorption of analyte on silanol groups was
done in order to measure binding energy of silanol – CTZ and
silanol – degradation product systems. Application of force
ﬁeldsmethod allowedmodeling of aforementioned systemswith
preservation of dipole effects. Models of structures are
presented (Fig. 4). Calculated binding energies were
946.71 kJ/mol and 773.45 kJ/mol for silanol-CTZ and
silanol-degradation product systems, respectively. Binding of
silanol-CTZ is 1.2 times stronger than silanol-degradation
product binding energy what stays in agreement with previous
investigations of dipole moment and ESP maps.
4. Conclusion
The proposed HPLC method exploiting hydrophilic interactions can
be recommended for the determination of cetirizine dihydrochloride
in the presence of its oxidation product in bulk substance and in solid
pharmaceutical dosage forms. Theoretical calculations conﬁrmed dif-
ferences in hydrophilic interactions of the analytes determined the var-
ious times of their elution.
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